On June 29, the Federal Service on Intellectual Property Rospatent published a list of 100 best inventions in Russia in 2011, which included patent No. 2435783 “Chimeric peptide and it’s pharmaceutical composition for cancer disease treatment”...
From 13 to 15 November 2012, the World Trade Center, Moscow, will host the XVI Russian Cancer Congress featuring expositions of the largest pharmaceutical and biotechnology companies in the Russian cancer market. The event will be attended by Skolkovo Biomedical...
Russian biotechnology company "MetaMax" that develops innovative products for the treatment of cancer, received the Eurasian patent №017179 "Pharmaceutical composition for the treatment of hyperproliferative diseases and its application"...
A Russian private biotechnology company Metamax, Ltd, financed by Maxwell Biotech Venture Fund, set up with the participation of RVC, has successfully completed the preclinical studies of the leading drug for treatment of colorectal cancer MM-D37K which is...